CN112730682B — 一种抗病毒药物临床研究血浆样本中奥司他韦及代谢物奥司他韦酸浓度的生物分析方法
Assigned to Suzhou Haike Medical Technology Co ltd · Expires 2022-06-17 · 4y expired
What this patent protects
本发明涉及一种抗病毒药物临床研究血浆样本中奥司他韦及代谢物奥司他韦酸浓度的生物分析方法,通过LC‑MS/MS对血浆中奥司他韦及代谢物奥司他韦酸进行分析。本发明方法优选采用蛋白沉淀预处理方法,以奥司他韦‑d5和奥司他韦酸‑d3为内标,采用Luna PFP色谱柱,梯度洗脱,电喷雾电离源(ESI)串联质谱检测。本发明操作简便、分析速度快、灵敏度高、线性范围合适,满足临床研究大批量样品分析需求。
USPTO Abstract
本发明涉及一种抗病毒药物临床研究血浆样本中奥司他韦及代谢物奥司他韦酸浓度的生物分析方法,通过LC‑MS/MS对血浆中奥司他韦及代谢物奥司他韦酸进行分析。本发明方法优选采用蛋白沉淀预处理方法,以奥司他韦‑d5和奥司他韦酸‑d3为内标,采用Luna PFP色谱柱,梯度洗脱,电喷雾电离源(ESI)串联质谱检测。本发明操作简便、分析速度快、灵敏度高、线性范围合适,满足临床研究大批量样品分析需求。
Drugs covered by this patent
- Xofluza (BALOXAVIR MARBOXIL) · Roche
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.